Lori Shafner

986 total citations
7 papers, 687 citations indexed

About

Lori Shafner is a scholar working on Immunology, Nephrology and Hematology. According to data from OpenAlex, Lori Shafner has authored 7 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Nephrology and 4 papers in Hematology. Recurrent topics in Lori Shafner's work include Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Blood groups and transfusion (3 papers). Lori Shafner is often cited by papers focused on Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Blood groups and transfusion (3 papers). Lori Shafner collaborates with scholars based in United States, United Kingdom and South Korea. Lori Shafner's co-authors include Scott T. Rottinghaus, Jong Wook Lee, Anita Hill, Hubert Schrezenmeier, Jeff Szer, Rasha Aguzzi, Alexander Röth, Andrew I. Damokosh, Austin Kulasekararaj and Flore Sicre de Fontbrune and has published in prestigious journals such as Blood, Haematologica and Blood Advances.

In The Last Decade

Lori Shafner

7 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Shafner United States 5 596 355 238 207 140 7 687
Claire Hall United Kingdom 6 575 1.0× 328 0.9× 296 1.2× 201 1.0× 98 0.7× 6 692
Paula Vieira‐Martins France 9 505 0.8× 311 0.9× 237 1.0× 130 0.6× 92 0.7× 10 588
Elisabetta Valoti Italy 13 1.1k 1.8× 844 2.4× 429 1.8× 157 0.8× 176 1.3× 21 1.2k
Anthony Nicholls United Kingdom 5 423 0.7× 237 0.7× 200 0.8× 80 0.4× 64 0.5× 8 590
Fanny Tabarin France 5 268 0.4× 184 0.5× 191 0.8× 79 0.4× 20 0.1× 7 540
Simona Brioschi Italy 5 863 1.4× 535 1.5× 401 1.7× 181 0.9× 148 1.1× 7 961
Cynthia Abarrategui-Garrido Spain 7 536 0.9× 303 0.9× 290 1.2× 71 0.3× 50 0.4× 8 565
György Sinkovits Hungary 12 227 0.4× 76 0.2× 116 0.5× 65 0.3× 4 0.0× 25 326
Wenjing Cao United States 14 425 0.7× 131 0.4× 366 1.5× 179 0.9× 5 0.0× 24 597
Apostolia Papalexandri Greece 9 128 0.2× 44 0.1× 153 0.6× 73 0.4× 4 0.0× 35 281

Countries citing papers authored by Lori Shafner

Since Specialization
Citations

This map shows the geographic impact of Lori Shafner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Shafner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Shafner more than expected).

Fields of papers citing papers by Lori Shafner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Shafner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Shafner. The network helps show where Lori Shafner may publish in the future.

Co-authorship network of co-authors of Lori Shafner

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Shafner. A scholar is included among the top collaborators of Lori Shafner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Shafner. Lori Shafner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Brodsky, Robert A., Régis Peffault de Latour, Scott T. Rottinghaus, et al.. (2020). Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria. Haematologica. 106(1). 230–237. 83 indexed citations
2.
Schrezenmeier, Hubert, Austin Kulasekararaj, L. Mitchell, et al.. (2019). S863 ONE-YEAR EFFICACY OF RAVULIZUMAB (ALXN1210) IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA NAIVE TO COMPLEMENT INHIBITORS. HemaSphere. 3(S1). 385–386. 2 indexed citations
3.
Kulasekararaj, Austin, Anita Hill, Scott T. Rottinghaus, et al.. (2018). Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study. Blood. 133(6). 540–549. 256 indexed citations
4.
Lee, Jong Wook, Flore Sicre de Fontbrune, Lily Wong Lee Lee, et al.. (2018). Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study. Blood. 133(6). 530–539. 264 indexed citations
5.
Brodsky, Robert A., Régis Peffault de Latour, Scott T. Rottinghaus, et al.. (2018). A Prospective Analysis of Breakthrough Hemolysis in 2 Phase 3 Randomized Studies of Ravulizumab (ALXN1210) Versus Eculizumab in Adults with Paroxysmal Nocturnal Hemoglobinuria. Blood. 132(Supplement 1). 2330–2330. 4 indexed citations
6.
Röth, Alexander, Scott T. Rottinghaus, Anita Hill, et al.. (2018). Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies. Blood Advances. 2(17). 2176–2185. 67 indexed citations
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Hall Breakdown of academic impact, for papers by Paula Vieira‐Martins Breakdown of academic impact, for papers by Elisabetta Valoti Breakdown of academic impact, for papers by Anthony Nicholls Breakdown of academic impact, for papers by Fanny Tabarin Breakdown of academic impact, for papers by Simona Brioschi Breakdown of academic impact, for papers by Cynthia Abarrategui-Garrido Breakdown of academic impact, for papers by György Sinkovits Breakdown of academic impact, for papers by Wenjing Cao Breakdown of academic impact, for papers by Apostolia Papalexandri
Rankless by CCL
2026